Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone

(2017) Esther L.G.E. Koedam et al.   JOURNAL OF ALZHEIMERS DISEASE

Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease

(2016) Gaël Chételat et al.   BRAIN

Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers

(2016) Mohamed Reda Bensaïdane et al.   JOURNAL OF ALZHEIMERS DISEASE

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition

(2014) Effie M Mitsis et al.   Molecular Neurodegeneration

Concomitant pathologies among a spectrum of parkinsonian disorders

(2014) Brittany N. Dugger et al.   PARKINSONISM & RELATED DISORDERS

Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus

(2014) Ville Leinonen et al.   Acta Neuropathologica Communications

Regional distribution of fibrillar amyloid deposition in the brain as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration

(2013) Laksanun Cheewakriengkrai et al.   Alzheimers & Dementia

Impact of18F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making

(2013) Anthony S. Zannas et al.   NEUROCASE

Practical utility of amyloid and FDG-PET in an academic dementia center

(2013) P. Sanchez-Juan et al.   NEUROLOGY

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

(2012) Juha O. Rinne et al.   ACTA NEUROPATHOLOGICA

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

(2012) Michael Grundman et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Impact of molecular imaging on the diagnostic process in a memory clinic

(2012) Rik Ossenkoppele et al.   Alzheimers & Dementia

Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease

(2012) C.G. Schipke et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

(2012) Thomas G. Beach et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients

(2012) Dean F. Wong et al.   MOLECULAR IMAGING AND BIOLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN